Banco Santander, S.A. Biogen Inc. Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$187.54 - $223.02 $919,696 - $1.09 Million	-4,904 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $528,410 - $665,769	2,727 Added 125.26%	4,904 $1.03 Million
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $5.26 Million - $6.76 Million	-23,487 Reduced 91.52%	2,177 $522,000
Q3 2021 Nov 08, 2021	BUY	$282.99 - $369.05 $20,092 - $26,202	71 Added 0.28%	25,664 $7.26 Million
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $6.17 Million - $9.88 Million	23,821 Added 1344.3%	25,593 $8.86 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $430,507 - $504,364	1,772 New	1,772 $496,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $751,306 - $1.13 Million	-3,180 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $2.82 Million - $3.25 Million	-10,645 Reduced 77.0%	3,180 $902,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $69.6 Million - $92.2 Million	-269,016 Reduced 95.11%	13,825 $3.7 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $2.72 Million - $3.45 Million	-10,126 Reduced 3.46%	282,841 $89.5 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $11 Million - $15.2 Million	-49,828 Reduced 14.54%	292,967 $86.9 Million
Q3 2019 Nov 06, 2019	BUY	$217.44 - $243.88 $73.9 Million - $82.8 Million	339,706 Added 10997.28%	342,795 $79.8 Million
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $77.3 Million - $85.3 Million	-352,712 Reduced 99.13%	3,089 $722,000
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $44.2 Million - $69.2 Million	204,042 Added 134.45%	355,801 $84.1 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $19.8 Million - $25.1 Million	71,083 Added 88.11%	151,759 $45.7 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $22.9 Million - $29.9 Million	77,876 Added 2781.29%	80,676 $28.5 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $89,874 - $107,111	349 Added 14.24%	2,800 $813,000
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $637,578 - $901,747	2,451 New	2,451 $671,000
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $49.2 Million - $57.7 Million	-175,000 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	175,000	175,000 $47.5 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account